News

Investigating Possible Securities Violations by Xiao-I Corporation

Investigating Possible Securities Violations by Xiao-I Corporation

Investigating Possible Securities Violations by Xiao-I Corporation

Glancy Prongay & Murray LLP, a national law firm known for advocating shareholder rights, has recently commenced a significant investigation on behalf of investors of Xiao-I Corporation (NASDAQ: AIXI). This inquiry aims to explore potential violations of federal securities laws that could have impacted investor interests.

Understanding the IPO and Initial Performance

Xiao-I Corporation held its initial public offering (IPO) around early March, offering 5.7 million American depository shares (ADSs) at an initial price of $6.80 each. This move raised an impressive $38.76 million for the company, positioning it to seize further growth opportunities in the burgeoning tech landscape. However, the underlying operations of the company soon came under scrutiny.

Recent Financial Disclosures and Impact

On September 25, 2023, Xiao-I shocked the market by announcing significant losses, reporting a net loss of $18.8 million for the first six months of 2023. This disclosure was alarming for investors, as the company’s total operating expenses surged by an astonishing 355% year-over-year, with R&D expenses skyrocketing by 708%. Following this disappointing news, the price of Xiao-I’s ADS plummeted by $2.70, resulting in a closing value of $16.29 per share—an unsettling drop of roughly 14.22% in one day.

Subsequent Financial Results and Ongoing Concerns

The situation further deteriorated when, on April 30, 2024, Xiao-I revealed its financial results for the entire year of 2023. The company reported revenues of only $59.2 million against a net loss widening to $27 million. Notably, R&D expenses continued to rise, growing by 118.3% compared to the previous year. The stock reacted negatively once again, with shares declining by 6.15% on the announcement date, closing at $10.98.

Compliance Issues with NASDAQ

Adding to the concerns, on July 15, 2024, it was disclosed that Xiao-I received a notification indicating non-compliance with NASDAQ's minimum bid price requirements. The news led to a quick reaction from investors, and the shares fell an additional $0.13, closing at $5.99, representing a 2.28% decrease. Such developments have raised eyebrows among analysts and investors alike, warranting a deeper examination of the company’s financial integrity and corporate governance.

Whistleblower Information and Investor Rights

Individuals possessing insider or non-public information about Xiao-I Corporation may opt to assist in the investigation or take advantage of the SEC Whistleblower Program. This initiative allows whistleblowers to potentially earn rewards of up to 30% of any successful financial recovery from the SEC. Those interested in learning more about their rights or participating in this program can reach out to Glancy Prongay & Murray LLP directly.

About Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP is recognized as a premier law firm specializing in representing investors and consumers within the scope of securities litigation and robust class action litigation. The firm has established a solid reputation, recently ranked by ISS Securities Class Action Services for its performance in securities class action settlements. With numerous successful outcomes and recoveries spanning various sectors, GPM's attorneys have demonstrated a steadfast commitment to advocating for investor rights across all industries, including technology, healthcare, and finance.

As developments unfold regarding Xiao-I Corporation and its ongoing investigation, GPM remains dedicated to keeping its clients informed. Investors are advised to stay updated and ensure they are aware of their rights during this period of scrutiny.

Frequently Asked Questions

What triggered the investigation by Glancy Prongay & Murray LLP?

The investigation was initiated due to potential violations of federal securities laws relating to Xiao-I Corporation, affecting investor interests.

How did Xiao-I Corporation perform during its IPO?

Xiao-I Corporation issued 5.7 million ADSs at $6.80 each, raising funds amounting to approximately $38.76 million.

What substance did the September 2023 financial report reveal about Xiao-I?

The company reported a significant net loss of $18.8 million for the first half of 2023, alongside a dramatic increase in operating expenses.

What compliance issues has Xiao-I faced recently?

The company received a letter from NASDAQ indicating non-compliance with minimum bid price requirements, leading to further declines in its ADS price.

How can whistleblowers assist in this investigation?

Whistleblowers with non-public information about Xiao-I can provide insights that may aid in the investigation, with potential rewards from the SEC for successful information leading to recovery.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 34

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 303

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 520

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 453

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 601

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 421

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading

Top 5 Most Recently Viewed Articles

Silexion Therapeutics to Showcase Innovations at Upcoming Conference

Updated Category News Views 127

Silexion Therapeutics and Its Future in Oncology Silexion Therapeutics Corp. is at the forefront of the biotechnology sector, focusing its efforts on innovative treatments specifically designed for oncology. This clinical-stage company is dedicated to transforming the landscape for patients with hard-to-treat cancers, primarily those with the mutated KRAS oncogene, known...

Continue Reading
UBS Predicts Slowdown in Nvidia-Led Tech Rally - Key Insights

Updated Category News Views 172

UBS Foresees Changes in Tech Rally Dynamics Analysts at UBS suggest that the excitement surrounding the recent tech rally, driven by Nvidia, is beginning to wane. They predict a shift towards a more volatile market environment, influenced by ongoing economic challenges and increasing regulatory scrutiny in the semiconductor sector. Analysts' Perspectives on Future Stock...

Continue Reading
OS Therapies (OSTX) Unveils Encouraging Survivorship Data

Updated Category News Views 222

OS Therapies Inc. Reports Promising Results in Bone Cancer Therapy OS Therapies Inc. (NYSE: OSTX), a company focused on developing innovative cancer treatments, recently reported compelling findings from its Phase 2b clinical trial on OST-HER2, an off-the-shelf immunotherapy designed for addressing osteosarcoma, a challenging form of bone cancer. Significant Survival Data...

Continue Reading
Jeito Capital Boosts Aviceda Therapeutics with $207.5M Funding

Updated Category News Views 239

Jeito Capital's Strategic Investment in Aviceda Therapeutics Jeito Capital has recently announced a significant investment in Aviceda Therapeutics, securing a substantial participation in an upsized $207.5 million Series C financing round aimed at advancing the company's lead program, AVD-104. This funding is specifically intended to support pivotal trials for AVD-104,...

Continue Reading
Apple's Innovative M4 Mac Mini Sets New Standards in Tech

Updated Category News Views 293

Apple Launches the Game-Changing Mac Mini Apple Inc (NASDAQ: AAPL) has once again captivated technology enthusiasts and consumers alike with its latest innovation — the redesigned Mac mini equipped with groundbreaking M4 and M4 Pro chips. This launch not only showcases Apple's commitment to performance but also its pioneering approach to sustainability, marking the Mac...

Continue Reading